172 related articles for article (PubMed ID: 32157124)
1. Serum metabolite profiles as potential biochemical markers in young adults with community-acquired pneumonia cured by moxifloxacin therapy.
Zhou B; Lou B; Liu J; She J
Sci Rep; 2020 Mar; 10(1):4436. PubMed ID: 32157124
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI).
Kuzman I; Bezlepko A; Kondova Topuzovska I; Rókusz L; Iudina L; Marschall HP; Petri T
BMC Pulm Med; 2014 Jun; 14():105. PubMed ID: 24975809
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
Wang Y; Zhang S; Li L; Xie J
Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of blood parameters for community-acquired pneumonia.
Huang Y; Liu A; Liang L; Jiang J; Luo H; Deng W; Lin G; Wu M; Li T; Jiang Y
Int Immunopharmacol; 2018 Nov; 64():10-15. PubMed ID: 30144639
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
[TBL] [Abstract][Full Text] [Related]
6. The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia.
Guo S; Mao X; Liang M
Respir Res; 2018 Oct; 19(1):193. PubMed ID: 30285748
[TBL] [Abstract][Full Text] [Related]
7. Elevated Plasma D-Dimer in Adult Community-Acquired Pneumonia Patients is Associated with an Increased Inflammatory Reaction and Lower Survival.
Ge YL; Liu CH; Wang N; Xu J; Zhu XY; Su CS; Li HL; Zhang HF; Li ZZ; Li HL; Zhang X; Chen H; Yu HL; Fu AS; Wang HY
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775898
[TBL] [Abstract][Full Text] [Related]
8. Assessment of inflammatory markers in patients with community-acquired pneumonia--influence of antimicrobial pre-treatment: results from the German competence network CAPNETZ.
Krüger S; Ewig S; Kunde J; Hartmann O; Marre R; Suttorp N; Welte T;
Clin Chim Acta; 2010 Dec; 411(23-24):1929-34. PubMed ID: 20699094
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics profile in acute respiratory distress syndrome by nuclear magnetic resonance spectroscopy in patients with community-acquired pneumonia.
Yan Y; Chen J; Liang Q; Zheng H; Ye Y; Nan W; Zhang X; Gao H; Li Y
Respir Res; 2022 Jun; 23(1):172. PubMed ID: 35761396
[TBL] [Abstract][Full Text] [Related]
10. Associations of Serum S100A12 With Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Prospective Cohort Study.
Jiang X; Huang CM; Feng CM; Xu Z; Fu L; Wang XM
Front Immunol; 2021; 12():714026. PubMed ID: 34745092
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
[TBL] [Abstract][Full Text] [Related]
12. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of serum procalcitonin in identifying the etiology of non-responding community-acquired pneumonia after initial antibiotic therapy].
Wang Z; Zhang X; Wu J; Zhang W; Kuang H; Li X; Xuan W; Wang K; Ma L
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Nov; 37(11):824-30. PubMed ID: 25604112
[TBL] [Abstract][Full Text] [Related]
14. Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin.
Bello S; Fandos S; Lasierra AB; Mincholé E; Panadero C; Simon AL; Gavin O; De Pablo F; Menendez R; Torres A
Respir Med; 2015 Sep; 109(9):1193-206. PubMed ID: 26205553
[TBL] [Abstract][Full Text] [Related]
15. Serial procalcitonin levels for predicting prognosis in community-acquired pneumonia.
Ito A; Ishida T; Tachibana H; Ito Y; Takaiwa T
Respirology; 2016 Nov; 21(8):1459-1464. PubMed ID: 27398948
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profiles in community-acquired pneumonia: developing assessment tools for disease severity.
Ning P; Zheng Y; Luo Q; Liu X; Kang Y; Zhang Y; Zhang R; Xu Y; Yang D; Xi W; Wang K; Chen Y; An S; Gao Z
Crit Care; 2018 May; 22(1):130. PubMed ID: 29759075
[TBL] [Abstract][Full Text] [Related]
17. Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia.
Kim MW; Lim JY; Oh SH
Scand J Clin Lab Invest; 2017 Nov; 77(7):486-492. PubMed ID: 28678546
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers and community-acquired pneumonia: tailoring management with biological data.
Torres A; Ramirez P; Montull B; Menéndez R
Semin Respir Crit Care Med; 2012 Jun; 33(3):266-71. PubMed ID: 22718212
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department].
Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Sicilia-Bravo I; Palomo-de Los Reyes MJ; Cabezas-Martínez A; Laín-Terés N; Estebaran-Martín J; Lozano-Ancín A; Cuena-Boy R
Enferm Infecc Microbiol Clin; 2014 Apr; 32(4):225-35. PubMed ID: 24182623
[TBL] [Abstract][Full Text] [Related]
20. Speed of recovery in adult patients with community-acquired pneumonia; moxifloxacin versus levofloxacin.
Wadi Al Ramahi J; Ramadan M; Jaber W; Abushanab L; Mughrabi M; Alshamayleh N; Mulhem A; Momani D; Obaidat M; Haddad G; Khalil B; Zahran A; Odat E; Kufoof N; Arabiat H; Diab A; Anzueto A
J Infect Dev Ctries; 2018 Oct; 12(10):878-886. PubMed ID: 32004157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]